#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Neurofibromatosis Cardiac failure acute Small cell lung cancer recurrent Drug eruption Palmoplantar pustulosis Soft tissue sarcoma Osteosarcoma recurrent Toxic epidermal necrolysis Hereditary hypophosphataemic rickets Precursor T-lymphoblastic lymphoma/leukaemia recurrent Renal cell carcinoma Congenital cystic kidney disease Warm autoimmune haemolytic anaemia Progressive familial intrahepatic cholestasis Metabolic disorder More trials…

    Learn about Rare Diseases

    Krabbe’s disease – Treatment Mastocytosis – Life with Disease IgA nephropathy Idiopathic inflammatory myopathy – Treatment Chondrosarcoma metastatic – Diagnostics Amyotrophic lateral sclerosis – Trials in Disease Rhabdoid tumour – Life with Disease Fabry’s disease – Life with Disease Chondrosarcoma – Treatment KBG syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sym024 Lovotibeglogene Autotemcel Levocarnitine Ima203Cd8 Nanatinostat COLESEVELAM HYDROCHLORIDE AZD1163 Mesalazine Tigecycline Degarelix Acetate Pf-06480605 Ozanimod Redasemtide Apixaban Pseudoephedrine Hydrochloride Pozelimab Carisbamate Ertapenem Sodium Protein S Sabestomig More therapies…

    Learn about Your Condition

    Thalassaemia alpha Acquired ATTR amyloidosis Ovarian granulosa cell tumour Cirrhosis alcoholic Rubella EGFR gene mutation Hodgkin's disease refractory Head and neck cancer Migraine with aura Oropharyngeal cancer recurrent Intestinal obstruction Vulvar dysplasia Hepatorenal syndrome Colorectal cancer metastatic Chondrosarcoma metastatic More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Testing Tuvusertib in Patients with Returning IDH and ATRX Mutant Astrocytoma Brain Tumor

    Recruiting

    2 1 1
    Investigated Drugs:
    • Tuvusertib
    Spain

  • Finding the Right Dose of Sugammadex to Reverse Rocuronium Muscle Relaxation in Children Under 2 Years of Age During Surgery

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Rocuronium Bromide
    • Sugammadex
    France

  • Comparing Sphenopalatine Block Using Lidocaine and Prilocaine to Blood Patch for Patients with Post-Dural Puncture Syndrome

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Anhydrous Lidocaine Hydrochloride
    • Lidocaine
    • Prilocaine
    France

  • A study testing DFL24498 eye drop solution to improve eye itching in adults with atopic keratoconjunctivitis

    Recruiting

    3 1 1
    Investigated Diseases:
    • Atopic keratoconjunctivitis
    Investigated Drugs:
    • (3S,6S,9S,12R,15S,18S,21S,24S,30S,33S,34R)-30-Ethyl-34-[(E,2R)-Hex-4-En-2-Yl]-4,7,10,12,15,19,25,28-Octamethyl-33-(Methylamino)-6,9,18,24-Tetrakis(2-Methylpropyl)-3,21-Di(Propan-2-Yl)-1-Oxa-4,7,10,13,16,19,22,25,28,31-Decazacyclotetratriacontane-2,5,8,11,14,17,20,23,26,29,32-Undecone Hydrochloride
    • Dexamethasone Phosphate
    Italy Spain

  • A Study of ANX005 for Patients Recently Diagnosed with Guillain-Barré Syndrome to Evaluate How the Drug Works in the Body and Its Safety

    Recruiting

    3 1 1
    Investigated Drugs:
    • HUMANISED IGG4 MONOCLONAL ANTIBODY AGAINST C1Q
    Denmark France Spain

  • A Study Comparing RLY-2608 and Fulvestrant with Capivasertib and Fulvestrant for Patients with PIK3CA-Mutant Hormone Receptor Positive, HER2-Negative Advanced Breast Cancer

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • RLY-2608
    • Capivasertib
    • Fulvestrant
    Austria Belgium Bulgaria Czechia Denmark France +10
Previous Page
1 … 103 104 105 106 107 … 1,646
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!